These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse. Löscher W J Pharmacol Exp Ther; 1978 Feb; 204(2):255-61. PubMed ID: 340640 [TBL] [Abstract][Full Text] [Related]
8. Identification of urinary metabolites of sodium dipropylacetate in man; potential sources of interference in organic acid screening procedures. Gompertz D; Tippett P; Bartlett K; Baillie T Clin Chim Acta; 1977 Jan; 74(2):153-60. PubMed ID: 318946 [TBL] [Abstract][Full Text] [Related]
9. Altered metabolic profiles of valproic acid in a patient with Reye's syndrome. Kuhara T; Inoue Y; Matsumoto M; Shinka T; Matsumoto I; Kitamura K; Fujii H; Sakura N Clin Chim Acta; 1985 Jan; 145(2):135-42. PubMed ID: 3918813 [TBL] [Abstract][Full Text] [Related]
10. Simple method for measuring valproate (epilim) in biological fluids. Willox S; Foote SE J Chromatogr; 1978 Apr; 151(1):67-70. PubMed ID: 346594 [No Abstract] [Full Text] [Related]
11. Accumulation of 3-hydroxyisobutyric acid, 2-methyl-3-hydroxybutyric acid and 3-hydroxyisovaleric acid in ketoacidosis. Landaas S Clin Chim Acta; 1975 Oct; 64(2):143-54. PubMed ID: 126826 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic studies with valproic acid in man. Klotz U Arzneimittelforschung; 1977; 27(5):1085-8. PubMed ID: 328019 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of sodium valproate in dog and mouse. Löscher W; Esenwein H Arzneimittelforschung; 1978; 28(5):782-7. PubMed ID: 373773 [TBL] [Abstract][Full Text] [Related]
14. [The metabolism of dipropylacetic acid dipropylacetamide. I. Identification and analysis in the urine by gas phase chromatography]. Pfaff MC; Mahuzier G Ann Pharm Fr; 1975; 33(6-7):355-63. PubMed ID: 769646 [No Abstract] [Full Text] [Related]
15. Dipropylacetate and propionyl CoA carboxylase. Wolf B Lancet; 1978 Aug; 2(8085):369. PubMed ID: 79729 [No Abstract] [Full Text] [Related]
16. The hydroxamate of valproic acid, a compound produced by oximation of urine from patients under valproic therapy. Libert R; Van Hoof F; Schanck A; Hoffmann E Biomed Environ Mass Spectrom; 1986 Nov; 13(11):599-603. PubMed ID: 2948586 [TBL] [Abstract][Full Text] [Related]
17. Disposition of valproic acid in man. Gugler R; Schell A; Eichelbaum M; Fröscher W; Schulz HU Eur J Clin Pharmacol; 1977 Oct; 12(2):125-32. PubMed ID: 336377 [TBL] [Abstract][Full Text] [Related]
18. Disposition of valproic acid in patients with liver disease. Klotz U; Rapp T; Müller WA Eur J Clin Pharmacol; 1978 Mar; 13(1):55-60. PubMed ID: 346355 [No Abstract] [Full Text] [Related]
19. Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog. Cone EJ; Darwin WD; Gorodetzky CW; Tan T Drug Metab Dispos; 1978; 6(4):488-93. PubMed ID: 28931 [TBL] [Abstract][Full Text] [Related]
20. Preliminary observations on valproic acid kinetics in patients with epilepsy. Johannessen SI Arzneimittelforschung; 1977; 27(5):1083-5. PubMed ID: 328018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]